(Q46003287)

18 December 2017

title

A randomized, placebo-controlled trial of aprotinin to reduce primary graft dysfunction following lung transplantation. (English)

1 reference

18 December 2017

1 reference

1 reference

placebo-controlled trial

1 reference

3

1 reference

18 December 2017

author name string

Cynthia S Herrington

1

1 reference

18 December 2017

Matthew E Prekker

2

1 reference

18 December 2017

Daniel Susanto

4

1 reference

18 December 2017

Jim W Baltzell

5

1 reference

18 December 2017

Leslie L Studenski

6

1 reference

18 December 2017

David M Radosevich

7

1 reference

18 December 2017

Rosemary F Kelly

8

1 reference

18 December 2017

Sara J Shumway

9

1 reference

18 December 2017

Marshall I Hertz

10

1 reference

18 December 2017

Hartmuth B Bittner

11

1 reference

18 December 2017

Peter S Dahlberg

12

1 reference

18 December 2017

publication date

19 August 2010

1 reference

18 December 2017

published in

Clinical Transplantation

1 reference

18 December 2017

volume

25

1 reference

18 December 2017

issue

1

1 reference

18 December 2017

page(s)

90-96

1 reference

18 December 2017

Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part V: predictors and outcomes

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01319.X

The effect of primary graft dysfunction on survival after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01319.X

Primary graft failure following lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01319.X

Clinical risk factors for primary graft failure following lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01319.X

Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01319.X

Risk factors for primary graft dysfunction after lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01319.X

Ischemia-reperfusion-induced lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01319.X

The antithrombotic and antiinflammatory mechanisms of action of aprotinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01319.X

Medium-term results of extracorporeal membrane oxygenation for severe acute lung injury after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01319.X

Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part I: introduction and methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01319.X

Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01319.X

Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part III: donor-related risk factors and markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01319.X

Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part IV: recipient-related risk factors and markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01319.X

Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part VI: treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01319.X

Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01319.X

The risk associated with aprotinin in cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01319.X

Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01319.X

Aprotinin--are there lessons learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01319.X

Aprotinin attenuated ischemia-reperfusion injury in an isolated rat lung model after 18-hours preservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01319.X

Addition of aprotinin to organ preservation solutions decreases lung reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01319.X

Aprotinin decreases reperfusion injury and allograft dysfunction in clinical lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2010.01319.X

10.1111/J.1399-0012.2010.01319.X

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017